Characteristic | Unadjusted prevalence ratio (95% Confidence Interval) | P | Adjusted prevalence ratio (95% Confidence Interval) | P |
---|---|---|---|---|
Sex | Â | Â | Â | Â |
 Male | Ref. |  |  |  |
 Female | 0.80 (0.71, 0.91) | 0.0008 | 0.78 (0.67, 0.90) | 0.0008 |
Age | Â | Â | Â | Â |
 18–24 | Ref. |  |  |  |
 25–29 | 0.98 (0.85, 1.14) | 0.79 | 0.88 (0.76, 1.02) | 0.09 |
  > 30 | 1.04 (0.88, 1.22) | 0.66 | 0.91 (0.77, 1.08) | 0.30 |
Education | Â | Â | Â | Â |
 None/some primary | Ref. |  |  |  |
 Primary/some secondary | 0.74 (0.65, 0.86) |  < 0.0001 | 0.76 (0.66, 0.88) | 0.0003 |
 Secondary or more | 0.59 (0.50, 0.69) |  < 0.0001 | 0.56 (0.47, 0.66) |  < 0.0001 |
Number of partners | Â | Â | Â | Â |
 0–1 | Ref. |  |  |  |
 2–5 | 1.43 (1.18, 1.72) | 0.0002 | 1.11 (0.83, 1.49) | 0.48 |
 6–10 | 1.41 (1.11, 1.80) | 0.0054 | 1.23 (0.89, 1.69) | 0.21 |
  > 11 | 1.31 (1.04, 1.65) | 0.023 | 1.30 (0.94, 1.81) | 0.11 |
Transactional sex | Â | Â | Â | Â |
 No | Ref. |  |  |  |
 Yes | 1.09 (0.96, 1.25) | 0.19 | – | – |
Non-injectable drug use | Â | Â | Â | Â |
 No | Ref. |  | Ref. |  |
 Yes | 1.43 (1.24, 1.65) |  < 0.0001 | 1.28 (1.10, 1.49) | 0.0012 |
HIV status | Â | Â | Â | Â |
 Living without HIV | Ref |  |  |  |
 Living with HIV | 1.03 (0.87, 1.20) | 0.76 | – | – |